1. Home
  2. AGS vs TBPH Comparison

AGS vs TBPH Comparison

Compare AGS & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGS
  • TBPH
  • Stock Information
  • Founded
  • AGS 2005
  • TBPH 2013
  • Country
  • AGS United States
  • TBPH United States
  • Employees
  • AGS N/A
  • TBPH N/A
  • Industry
  • AGS Miscellaneous manufacturing industries
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • AGS Consumer Discretionary
  • TBPH Health Care
  • Exchange
  • AGS Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • AGS 455.5M
  • TBPH 394.4M
  • IPO Year
  • AGS 2018
  • TBPH N/A
  • Fundamental
  • Price
  • AGS $11.63
  • TBPH $8.62
  • Analyst Decision
  • AGS Hold
  • TBPH Buy
  • Analyst Count
  • AGS 4
  • TBPH 4
  • Target Price
  • AGS $12.63
  • TBPH $13.75
  • AVG Volume (30 Days)
  • AGS 208.7K
  • TBPH 202.7K
  • Earning Date
  • AGS 11-05-2024
  • TBPH 11-05-2024
  • Dividend Yield
  • AGS N/A
  • TBPH N/A
  • EPS Growth
  • AGS 21.27
  • TBPH N/A
  • EPS
  • AGS 0.11
  • TBPH N/A
  • Revenue
  • AGS $376,241,000.00
  • TBPH $62,017,000.00
  • Revenue This Year
  • AGS $9.93
  • TBPH $6.93
  • Revenue Next Year
  • AGS $4.38
  • TBPH $45.31
  • P/E Ratio
  • AGS $105.36
  • TBPH N/A
  • Revenue Growth
  • AGS 12.98
  • TBPH 20.97
  • 52 Week Low
  • AGS $6.76
  • TBPH $7.44
  • 52 Week High
  • AGS $11.75
  • TBPH $11.71
  • Technical
  • Relative Strength Index (RSI)
  • AGS 72.19
  • TBPH 62.93
  • Support Level
  • AGS $11.58
  • TBPH $7.88
  • Resistance Level
  • AGS $11.66
  • TBPH $8.81
  • Average True Range (ATR)
  • AGS 0.06
  • TBPH 0.22
  • MACD
  • AGS 0.01
  • TBPH 0.08
  • Stochastic Oscillator
  • AGS 72.00
  • TBPH 79.57

About AGS PlayAGS Inc.

PlayAGS Inc is a designer and supplier of gaming products and services for the gaming industry. The company mainly supplies electronic gaming machines (EGM), server-based systems and back-office systems which are used by casinos, and various gaming locations. Its operating segments are EGM, Table Products, and Interactive. The EGM segment offers a selection of video slot titles developed for the world-wide marketplace as well as EGM cabinets. Its Table Products segments include live proprietary table games and side bets, as well as ancillary table products. The Interactive segment consists of delivering games through mobile apps such as Lucky Play Casino and Vegas Fever. It earns a majority of its revenue from Electronic Gaming Machines segment and geographically from the United States.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: